Skip to main content

Table 1 Patient characteristics for contact or no contact with a MDT-HRFS

From: Primary care referral to multidisciplinary high risk foot services – too few, too late

 

Contact (n = 40)

No Contact (n = 116)

Total (n = 156)

p-value

Demographics

 Mean Age (±SD)

63.4 (±11.8)

65.5 (±14.1)

65 (±13.5)

0.40

 Male, n (%)

27 (67.5)

78 (67.2)

105 (67.3)

 

 Female, n (%)

13 (32.5)

38 (32.8)

51 (32.7)

0.98

Medical history

 Diabetes Type 1, n (%)

4 (10.0)

8 (6.9)

12 (7.7)

 

 Diabetes Type 2, n (%)

36 (90.0)

108 (93.1)

144 (92.3)

0.54

 Duration of Diabetes (±SD)

15.5 (±5.7)

15.8 (±8.5)

15.7 (±7.8)

0.86

 HbA1C (mmol/mol)/IFCC

8.4 (±2.2)/68

8.7 (±2.6)/72

8.6 (±2.5)/70.5

0.44

 Peripheral Neuropathy, n (%)

35 (87.5)

97 (83.6)

132 (84.6)

0.56

 Peripheral Arterial Disease, n (%)

33 (82.5)

95 (81.9)

128 (82.1)

0.93

 Ischemic Heart Disease, n (%)

20 (50)

58 (50)

78 (50)

1.00

 Hypertension, n (%)

36 (90)

98 (84.5)

134 (85.9)

0.39

 CKD stage 5, n (%)

9 (22.5)

19 (16.4)

28 (17.9)

0.21

 eGFR (±SD)

41.3 (±26.5)

47.8 (±28.7)

46.2 (±28.2)

0.001*

 Length of Stay, n (IQR)

8 (7–12)

11 (6–24)

10 (10–19.5)

0.63

LAB

 White Cell Count, n (IQR)

10.75 (8–15)

12.1 (10–15)

11.8 (9–15)

0.24

 Presenting ESR (mmol/L), n (IQR)

57 (34–86)

57 (26–77)

57 (27–77)

0.69

 Presenting CRP (mg/l), n (IQR)

76.35 (23–155)

69.75 (32–172)

73.7 (29–166)

0.99

Infection severity

 IDSA grade Moderate, n (%)

28 (70 %)

77 (66.4 %)

105 (67.3 %)

0.68

 IDSA grade Severe, n (%)

12 (30 %)

39 (33.6 %)

51 (32.7 %)

0.68

Texas classification

 1B, n (%)

1 (2.5)

6 (5.2)

7 (4.5)

0.48

 1D, n (%)

6 (15)

21 (18.1)

27 (17.3)

0.66

 2B, n (%)

3 (7.5)

11 (9.5)

14 (9)

0.71

 2D, n (%)

12 (30)

52 (44.8)

64 (41)

0.10

 3B, n (%)

3 (7.5)

5 (4.3)

8 (5.1)

0.43

 3D, n (%)

15 (37.5)

21 (18.1)

36 (23.1)

0.01*

Surgery type

 Surgical debridement, n (%)

7 (17.5)

28 (24.1)

35 (22.4)

0.39

 PTA, n (%)

6 (15)

34 (29.3)

40 (25.6)

0.08*

 Bypass, n (%)

0 (0)

3 (2.6)

3 (1.9)

0.31

 Amputation, n (%)

23 (57.5)

77 (66.4)

100 (64.1)

0.32

 Forefoot/digital, n (%)

16 (40)

51 (44)

67 (42.9)

0.66

 TMA, n (%)

0 (0)

0 (0)

0 (0)

 

 BKA, n (%)

8 (20)

18 (15.5)

26 (16.7)

0.51

 AKA, n (%)

0 (0)

8 (6.9)

8 (5.1)

0.09*

  1. ESR erythrocyte sedimentation rate, CRP c-reactive protein, CKD chronic kidney disease, eGFR estimated glomelular filtration rate, PTA percutaneous transluminal angioplasty
  2. *p-value <0.05